These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2421393)

  • 1. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenoxybenzamine for symptoms of bladder neck obstruction.
    Drug Ther Bull; 1983 Feb; 21(4):15-6. PubMed ID: 6187524
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
    Kondo A; Narita H; Otani T; Kobayashi M; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1232-40. PubMed ID: 83419
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment of lower urinary tract dysfunction in the female patient.
    Wein AJ
    Urol Clin North Am; 1985 May; 12(2):259-69. PubMed ID: 2859679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapy of functional disorders of the lower urinary tract in the female. 2: Drug therapy of stress incontinence, bladder muscle weakness and increased bladder outflow resistance].
    Schumacher T; Peters FD
    Fortschr Med; 1984 Sep; 102(36):906-8. PubMed ID: 6489903
    [No Abstract]   [Full Text] [Related]  

  • 10. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P; Ballanger P
    J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urological complications in patients with multiple sclerosis (author's transl)].
    Kiesswetter H; Flamm J; Hennrich F; Summer K; Schober W
    Wien Klin Wochenschr; 1980 Jan; 92(1):16-22. PubMed ID: 6929626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment.
    Austin PF
    J Urol; 2010 Feb; 183(2):730. PubMed ID: 20022040
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
    Lardennois B; El Khansa A; Amory JP; Coulon JM; Lemaire P
    J Urol (Paris); 1981; 87(4):243-8. PubMed ID: 6167646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH.
    de Mey C
    Eur Urol; 1998; 34 Suppl 2():18-28; discusion 47. PubMed ID: 9732829
    [No Abstract]   [Full Text] [Related]  

  • 18. [Personal experiences with phenoxybenzamine (Dibenzyran) in the treatment of functional disorders of bladder emptying].
    Wehnert J; Sage S
    Z Urol Nephrol; 1988 Mar; 81(3):153-8. PubMed ID: 3388995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.
    Van Batavia JP; Combs AJ; Horowitz M; Glassberg KI
    J Urol; 2010 Feb; 183(2):724-30. PubMed ID: 20022041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of "Ubretid" in the field of urology].
    Inada T; Ebisuta K; Harada T
    Hinyokika Kiyo; 1967 May; 13(5):429-32. PubMed ID: 4169450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.